TELESCOPE INNOVATIONS CP (TELIF) Stock News, Sep 2024-Apr 2025

Telescope Innovations Corp (CSE: TELI) (OTCQB: TELIF) provides an update on its Self-Driving Lab (SDL) technology development. SDLs combine AI, robotics, and advanced chemistry analytics to accelerate R&D processes 10-100 times faster than traditional methods.

The company has strengthened its position through a master collaborative agreement with Pfizer and becoming a Certified Systems Integrator with Universal Robots. Telescope has expanded its team by 33% over the past six months, enhancing expertise in chemistry, engineering, robotics, and AI-driven automation.

CTO Prof. Jason Hein has engaged with leading institutions including Seoul National University and Korean institutes to strengthen international partnerships. The company focuses on accelerating research in pharmaceuticals, industrial chemicals, and critical minerals, positioning itself to create value in the AI-powered scientific landscape.

Telescope Innovations Corp (CSE: TELI) (OTCQB: TELIF) has announced its listing on the Frankfurt Stock Exchange (FSE) under the ticker symbol 'J4U'. This strategic move expands the company's visibility and accessibility to European investors, complementing its existing listings on the Canadian Securities Exchange and OTCQB.

The company operates at the intersection of AI, robotics, advanced analytics, and chemical process innovation, developing intellectual property and automation tools for research and manufacturing efficiency. Telescope serves the pharmaceutical, industrial chemical, and critical materials sectors through world-class partnerships and industry-leading customers.

The FSE listing is expected to increase trading liquidity and provide greater exposure to international investors, particularly in Europe's chemical and pharmaceutical industries where the company has established commercial relationships.

Telescope Innovations (CSE: TELI) (OTCQB: TELIF) announced that its Founder and Chief Technology Officer, Professor Jason Hein, has been awarded the 2025 R.U. Lemieux Award by the Chemical Institute of Canada. The award recognizes his contributions to organic chemistry and pioneering research in reaction mechanisms and process development.

Professor Hein leads Telescope's technological vision, focusing on reaction automation, AI-driven chemical research, and robotics for scalable, sustainable chemical manufacturing. His work aims to accelerate the development of next-generation processes for the pharmaceutical and fine chemical industries.

The R.U. Lemieux Award, presented by the Canadian Society for Chemistry, celebrates excellence in organic chemistry and recognizes distinguished contributions to the field.

Telescope Innovations Corp (CSE: TELI) (OTCQB: TELIF) reported Q1 FY2025 financial results with revenues of $1.2 million, down from $1.5 million in Q1 FY2024. The company recorded an adjusted EBITA loss of $103,177, compared to earnings of $505,171 in the same period last year. Expenses increased to $1.5 million from $1.3 million year-over-year.

Key operational highlights include successful delivery of DirectInject-LC™ products under the Mettler Toledo distribution agreement, with product demonstrations across multiple countries. The company advanced its Self-Driving Labs research with Pfizer, achieving Certified Systems Integrator status for Universal Robots systems. Additionally, Telescope demonstrated production of >99.5% pure lithium carbonate using its ReCRFT™ technology and is building a pilot plant in Vancouver for scale-up studies.

Telescope Innovations (CSE: TELI, OTCQB: TELIF) has announced successful results from its Brine-to-Battery Program, demonstrating the production of battery-grade lithium carbonate (>99% pure) from various North American lithium brines using its proprietary ReCRFT™ technology.

The technology has proven effective with brines from Alberta, Texas, Nevada, and Arkansas, processing materials with original lithium purity ranging from 15% to 93%. Key advantages of ReCRFT™ include elimination of traditional polishing steps in lithium carbonate production from Direct Lithium Extraction (DLE) concentrates, reducing reagent, equipment, energy, and operating costs.

The company has protected the ReCRFT™ technology through a patent application under the Patent Cooperation Treaty and additional jurisdictions, positioning itself to address North America's critical minerals supply challenges.

Telescope Innovations Corp (CSE: TELI) (OTCQB: TELIF) reported financial results for fiscal year 2024, showing revenue growth of 57% to $4.4M from $2.8M in FY2023. The company posted an Adjusted EBITDA loss of $152K, improved from a $225K loss in FY2023. Expenses increased to $5.8M from $3.5M previous year.

Key achievements include launching a multi-year collaboration with Pfizer for self-driving labs development, securing a global distribution agreement with Mettler Toledo for DirectInject-LC™, and obtaining funding for a lithium refinement pilot plant. The company also advanced new IP in lithium sulfide production and battery recycling technologies.

Telescope Innovations (CSE: TELI) (OTCQB: TELIF) has published research demonstrating an AI-driven method to optimize battery-grade lithium carbonate production. The study, conducted with Natural Resources Canada, McMaster University, and the University of Toronto, showcases the company's ReCRFT technology, which achieved over 83% lithium carbonate yields from direct lithium extraction eluates using CO2 as a carbonating reagent. The process specifically addresses challenges in processing North American brines, which contain high impurities and typically require multiple polishing steps.

Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) has achieved Certified Systems Integrator (CSI) status for robotic instruments sold by Universal Robots (UR). This certification enables faster development and deployment of Telescope's Self-Driving Labs (SDLs), which combine advanced process analytical technology, AI, and robotics to accelerate chemistry research.

The CSI status provides Telescope with two key advantages:

• Faster development cycles for SDLs, which aim to optimize chemical synthesis and manufacturing approaches up to 100x faster than traditional methods
• Facilitated deployment of SDLs for clients, including installation, testing, and training with UR robots

This certification strengthens Telescope's position as integrators-of-choice for companies seeking advanced chemical technologies, allowing them to build and deploy more powerful SDLs.

Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) and Altillion Inc. have successfully collaborated to produce battery-quality lithium carbonate from brines. Telescope's proprietary ReCRFT™ recrystallization technology, applied to lithium-containing brines concentrated via Altillion's ALIX process, consistently yielded lithium carbonate exceeding 99.9% purity.

This collaboration aims to establish a secure, sustainable, and on-shore supply of high-purity lithium carbonate for North American battery raw materials. The combined technologies simplify the traditional 5-step lithium brine processing into a more efficient 2-step process, potentially reducing costs and improving energy efficiency. Telescope is now building a lab-scale ReCRFT™ pilot plant in Vancouver, BC, to further advance this goal.